ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 294 filers reported holding ISIS PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $269,399,000 | -16.9% | 6,665 | +18.4% | 0.20% | -12.0% |
| Q2 2015 | $324,007,000 | +6.6% | 5,630 | +17.9% | 0.22% | +7.1% |
| Q1 2015 | $304,024,000 | +2.6% | 4,775 | -0.5% | 0.21% | +2.9% |
| Q4 2014 | $296,352,000 | +59.0% | 4,800 | 0.0% | 0.20% | +52.2% |
| Q3 2014 | $186,384,000 | +12.7% | 4,800 | 0.0% | 0.13% | +13.6% |
| Q2 2014 | $165,360,000 | -20.3% | 4,800 | 0.0% | 0.12% | -20.3% |
| Q1 2014 | $207,408,000 | +0.5% | 4,800 | -12.7% | 0.15% | -13.5% |
| Q3 2013 | $206,470,000 | – | 5,500 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 6,417,548 | $255,675,000 | 13.66% |
| HWG Holdings LP | 339,799 | $13,538,000 | 8.73% |
| DOWLING & YAHNKE LLC | 675,798 | $26,924,000 | 3.78% |
| GARRISON BRADFORD & ASSOCIATES INC | 99,300 | $3,956,000 | 3.74% |
| WILLIAM HARRIS INVESTORS INC | 283,834 | $11,308,000 | 3.35% |
| SECTORAL ASSET MANAGEMENT INC | 1,222,401 | $48,700,000 | 2.10% |
| AVALON CAPITAL MANAGEMENT | 49,999 | $1,992,000 | 1.68% |
| PINNACLE ASSOCIATES LTD | 2,016,369 | $80,332,000 | 1.57% |
| PERKINS CAPITAL MANAGEMENT INC | 48,515 | $1,933,000 | 1.30% |
| NCM Capital Advisers, Inc. | 31,100 | $1,239,000 | 1.28% |